Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial

Stroke

Volumn 28, Issue 11, 1997, Pages 2119-2125

  Lyden, Patrick ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral ischemia; Clinical trials; Plasminogen activators; Thrombolytic therapy

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STROKE; TREATMENT OUTCOME;

EID: 0343990052     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.str.28.11.2119     Document Type: Article

References (15)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Report of the Quality Standards Subcommittee of the American Academy of Neurology: Thrombolytic therapy for acute ischemic stroke: summary statement. Neurology. 1996;47:835-839.
3. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation. 1996;94:1167-1174.
4. Furlan A, Kanoti G. When is thrombolysis justified in patients with acute ischemic stroke? A bioethical perspective. Stroke. 1997;28: 214-218.
5. Tilley BC, Marler J, Geller NL, Lu M, Legler J, Brott T, Lyden P, Grotta J. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Trial. Stroke. 1996;27:2136-2142.
6. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J, NINDS t-PA Stroke Study Group. Improved reliability of the NIH Stroke Scale using video training. Stroke. 1994;25:2220-2226.
7. Yusuf S, Wittes J, Probstfield J, Tyroler H. Analysis and interpretations of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-98.
8. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
9. Cohen J, Cohen P. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1983.
10. Nagelkerke N. A note on a general definition of the coefficient of determination. Biometrika. 1991;78:691-692.
11. Carlberg B, Asplund K, Hägg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke. 1993;24: 1372-1375.
12. Loewen SC, Anderson BA. Predictors of stroke outcome using objective measurement scales. Stroke. 1990;21:78-81.
13. Katz S, Ford AB, Chinn AB, Newill VA. Prognosis after strokes, II: long-course of 159 patients. Medicine. 1966;454:236-246.
14. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;131:1121-1123.
15. Tomsick TA, Brott TG, Chambers AA, Fox AJ, Gaskill MF, Lukin RR, Pleatman CW, Wiot JG, Bourekas E. Hyperdense middle cerebral artery sign on CT: efficacy in detecting middle cerebral artery thrombosis. AJNR Am J Neuroradiol. 1990;11:473-477.